UNITED STATES
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934


             (Exact name of registrant as specified in its charter)

            DELAWARE                     1-9210              95-4035997
  (State or other jurisdiction        (Commission         (I.R.S. Employer
        of incorporation)             File Number)       Identification No.)

              10889 WILSHIRE BOULEVARD
              LOS ANGELES, CALIFORNIA                             90024
      (Address of principal executive offices)                 (ZIP code)

               Registrant's telephone number, including area code:
                                 (310) 208-8800


Check the appropriate box below if the Form 8-K is intended to simultaneously
satisfy the filing obligation of the Registrant under any of the following
provisions (see General Instruction A.2. below):

[   ]  Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)

[   ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)

[   ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))

[   ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))


Item 1.01.  Entry into a Material Definitive Agreement
----------  ------------------------------------------

     On February 10, 2005, the Board of Directors of Occidental Petroleum
Corporation ("Occidental") approved an extension of the November 2000 employment
agreement with Dr. Ray R. Irani, Occidental's Chairman, President and Chief
Executive Officer. The new amended and restated agreement extends the term from
May 2007 to May 2010, and also clarifies that salary increases and bonus awards
may be paid in Occidental common stock, cash or a combination of both, and
increases his life insurance coverage following retirement from two to three
times his highest annual salary. In addition, certain technical corrections were
made to comply with the 2004 American Jobs Creation Act.

     A summary of the terms and conditions of the amended and restated agreement
is as follows:

     The agreement, as amended and restated, is for a term expiring on the
earlier of Occidental's 2010 Annual Meeting of Stockholders or May 30, 2010 with
an annual salary at a minimum rate of $1,300,000, subject to annual increase
(and, as part of across-the-board reductions for other officers, decrease), as
well as an annual cash bonus, in each case at the reasonable discretion of the
Board of Directors and the Executive Compensation and Human Resources Committee
(the "Committee"). Salary increase and bonuses may be paid at the discretion of
the Committee in cash, common stock or a combination thereof. In addition, Dr.
Irani is eligible to participate in Occidental's group life insurance, medical
and dental care (including coverage for his wife and children), disability,
retirement, personal savings account, deferred compensation and other plans or
benefits which Occidental may provide for employees and other senior executives.
During the term and thereafter until his death, Dr. Irani will receive life
insurance at least equal to three times his highest career annual salary, which
life insurance shall be assignable at Dr. Irani's option. Prior to retirement,
Dr. Irani will receive six weeks paid vacation each calendar year (which will
accrue and for which he will be entitled to be paid for any accrued but unused
vacation time upon termination of the agreement) and the minimum perquisites to
which he was entitled prior to November 30, 2000.

     Following his retirement or upon the termination of his employment by
Occidental, Dr. Irani will continue to receive medical and dental benefits no
less favorable than those provided prior to his retirement or termination and
his existing perquisites, including the personal tax, accounting and financial
planning services currently provided to him. Upon retirement, notwithstanding
the provisions of the award agreements, all of Dr. Irani's unvested stock
options and SARs and restricted stock awards will immediately vest and become
exercisable and his performance stock awards will become immediately vested and
fully payable. If the agreement is terminated due to Dr. Irani's death, Dr.
Irani's estate will be entitled to a pro rata portion of any bonus he was
eligible to receive for the year of his death. If Dr. Irani is married at the
time of his death, his wife will be entitled, for the remainder of her life, to
continuation of medical benefits. If Dr. Irani is terminated by Occidental for
any reason, or if Dr. Irani terminates employment because Occidental materially
breaches the agreement, Dr. Irani is entitled to receive three times his highest
annual salary and bonus for any calendar year commencing with January 1, 2000
(subject to certain offsets of disability benefits in the case of termination
due to disability), without obligation to mitigate, payable in an undiscounted
lump sum not later than two and one half months from the end of the calendar
year in which the termination occurs. In such event of termination, Dr. Irani is
also entitled to receive his medical, dental, welfare and life insurance
benefits; his existing perquisites and the full and immediate vesting of his
restricted stock, stock


options and any other long-term incentive benefits; provided that the options or
stock appreciation rights shall be exercisable as if he had retired on such
date. If after termination of his employment, Dr. Irani is not eligible to
participate in Occidental's benefit plans as contemplated by his employment
agreement, then Occidental will provide Dr. Irani with substantially equivalent
benefits and will reimburse him for any additional tax liabilities incurred by
him as a result of his receipt of such benefits. If Occidental materially
breaches the agreement and does not cure the breach after notice thereof, Dr.
Irani may terminate his employment and treat such occurrence as if it were a
termination by Occidental; provided that it shall not be a material breach if,
following the merger or sale of Occidental or substantially all of its assets,
Dr. Irani continues to have substantially the same executive duties and reports
to the acquirer's board of directors. The agreement also holds Dr. Irani
harmless from the effects of any excise or other taxes payable under or as a
result of Sections 280G and 4999 of the Internal Revenue Code of 1986 or
comparable state law by reason of a change of control, including taxes payable
on any amounts paid pursuant to this hold harmless provision.

     During and after the term of the agreement, Dr. Irani is entitled to the
payment of all legal fees other than those of a purely personal nature. In
addition, the agreement provides for additional indemnification for Dr. Irani to
the fullest extent permitted by applicable law and for Occidental to maintain
Directors' and Officers' liability insurance with policy limits aggregating not
less than $100 million, insuring Dr. Irani against occurrences which occur
during the term of the agreement.



Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                              OCCIDENTAL PETROLEUM CORPORATION

DATE: February 15, 2005       S. P. Dominick, Jr.
                              S. P. Dominick, Jr., Vice President and Controller
                              (Chief Accounting and Duly Authorized Officer)